Amber

When you optimize a stain you are normally just looking at one tissue type or 
possible a couple, not sure how you handle protocol development.  The amount of 
work that is required for validation in the clinical setting is dependent upon 
the type of primary antibody that you are using.  If it is an IVD antibody I 
believe that verification is only required.  You need to verify that this 
antibody works as stated in your laboratory.

If you are using an RUO antibody you have go through a validation process.  
This in my opinion includes two steps.

1. protocol development and optimization
2. validation - you are checking for sensitivity, specificity and 
reproducibility on multiple tissue samples

The CAP has a paper that has recommendations for validation (standardization of 
IHC) for validation they want you to look at 25 different tissue samples, 10 of 
which are strong positive, 10 which are weak to moderately positive and 5 that 
are negative.  In the case of prognostic and treatment related IHC they suggest 
that more tissues are evaluated.  New lots require 3 tissues; strong positive, 
weak to moderate, and negative.

Ultimately the your laboratory will come up with some system as how you are 
going to approach this.  This is just a really basic overview and there is a 
lot more that can be added.  In my opinion I think you need to do what makes 
sense in your laboratory.  I would have a defined SOP for how you handle 
certain types of antibodies.

Just my two cents.

Liz

Elizabeth A. Chlipala, BS, HTL(ASCP)QIHC
Manager
Premier Laboratory, LLC
PO Box 18592
Boulder, CO 80308-1592
(303) 682-3949 office
(303) 682-9060 fax
(303) 881-0763 cell
www.premierlab.com

Ship to address:

1567 Skyway Drive, Unit E
Longmont, CO 80504

-----Original Message-----
From: histonet-boun...@lists.utsouthwestern.edu 
[mailto:histonet-boun...@lists.utsouthwestern.edu] On Behalf Of Amber McKenzie
Sent: Wednesday, November 16, 2011 11:21 AM
To: histonet@lists.utsouthwestern.edu
Subject: [Histonet] Validation


Just wondering what y'alls opinion is on validation:  I don't really understand 
why optimization isn't enough.  At that point, the pathologist has said what he 
wanted the stain to look like, so why do 3-10 positive slides on the new 
instrument to compare to previous slides from another instrument?  Thanks!

_______________________________________________
Histonet mailing list
Histonet@lists.utsouthwestern.edu
http://lists.utsouthwestern.edu/mailman/listinfo/histonet

_______________________________________________
Histonet mailing list
Histonet@lists.utsouthwestern.edu
http://lists.utsouthwestern.edu/mailman/listinfo/histonet

Reply via email to